BackProtalix BioTherapeutics Overview

Protalix BioTherapeutics Total Revenue

Revenue analysis for PLX.

Quarterly Revenue

$33.75M
↑ 233.73% YoY

As of Mar 2026

Annual Revenue (TTM)

$76.38M
↑ 27.8% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin